Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients

NCT04954157 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04954157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04954157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2020
Completion date
April 21, 2022
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid bodies, hypoxia, sars-cov-2 acute respiratory disease